Combining therapeutic antibodies using basiliximab and etanercept for severe steroid-refractory acute graft-versus-host disease: A multi-center prospective study.
Tan Y, Xiao H, Wu D, Luo Y, Lan J, Liu Q, Yu K, Shi J, He J, Zheng W, Lai X, Zhu Y, Du K, Ye Y, Zhao Y, Zheng G, Hu Y, Han X, Zheng Y, Wei G, Cai Z, Huang H.
Tan Y, et al. Among authors: hu y.
Oncoimmunology. 2017 Jan 6;6(3):e1277307. doi: 10.1080/2162402X.2016.1277307. eCollection 2017.
Oncoimmunology. 2017.
PMID: 28405499
Free PMC article.